跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ledipasvir/Sofosbuvir
首页
药物
Ledipasvir/Sofosbuvir
Ledipasvir/Sofosbuvir
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Sofosbuvir and ledipasvir compound preparation
申请人: BEIJING WINSUNNY PHARMACEUTICAL CO LTD
优先权: 2016
CN
PHARMACEUTICAL COMPOSITIONS COMPRISING LEDIPASVIR AND SOFOSBUVIR
申请人: SANDOZ AG
优先权: 2015
CN
Ledipasvir and sofosbuvir compound coating tablet preparation and preparation method thereof
申请人: ANHUI YELLEN PHARMACEUTICAL CO LTD
优先权: 2014
CN
Ledipasvir and sofosbuvir compound tablets and preparation method and application thereof
申请人: SHANGHAI BOCIMED PHARMACEUTICAL CO LTD
优先权: 2016
CN
2 件公开
COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS
申请人: GILEAD PHARMASSET LLC
优先权: 2013
CN
EP
US
5 件公开
METHODS FOR TREATING HEPATITIS C VIRUS INFECTION
申请人: GILEAD PHARMASSET LLC
优先权: 2014
US
THERAPEUTIC TARGETS AND AGENTS FOR THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER
申请人: US GOV VETERANS AFFAIRS
优先权: 2022
US
药物
反馈